nidНефрология и диализNephrology and Dialysis1680-44222618-9801Российское диализное обществоnid-3792Research Article22.10.99, МОСКВА, II СЪЕЗД НЕФРОЛОГОВ РОССИИ, СИМПОЗИУМ «ПЕРИТОНЕАЛЬНЫЙ ДИАЛИЗ: СОВРЕМЕННОЕ СОСТОЯНИЕ ВОПРОСА»Влияние перитонита на эффективность перитонеального диализаInfluence of Peritonitis on Efficacy of Peritoneal DialysisАндрусевА. М.AndrusevA. M.noemail@neicon.ruТитоваН. Л.TitovaN. L.noemail@neicon.ruТомилинаН. А.TomilinaN. A.noemail@neicon.ruГородская клиническая больница № 52, Московский городской нефрологический центрRussian Federation20002806202521-2101107Copyright © Андрусев А.М., Титова Н.Л., Томилина Н.А., 20252025Андрусев А.М., Титова Н.Л., Томилина Н.А.Andrusev A.M., Titova N.L., Tomilina N.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.nephro.ru/jour/article/view/3792

Перитонеальный диализ (ПД) вошел в широкую клиническую практику как метод заместительной терапии при хронической почечной недостаточности (ХПН) в начале 80-x гг., когда были обоснованы его физиологические механизмы и разработаны коммерческие растворы, а также методики наиболее безопасного постоянного перитонеального доступа. В последние годы ПД интенсивно развивается в большинстве стран. В 1997 г. в мире его получали 115 000 больных, причем их ежегодный прирост составил 7-14% [6].

перитонеальный диализдиализный перитонитKT/Vсредневысокие транспортерыReferencesChurchill D.N., Thorpe K.E., Nolph K.D., Keshaviah P.R., Oreopou-los D.G., Page D. Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. J.Am Soc.Nephrol.1998; 9: 1285-1292.Churchill D.N., Thorpe K.E., Nolph K.D., Keshaviah P.R., Oreopou-los D.G., Page D. Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. J.Am Soc.Nephrol.1998; 9: 1285-1292.Davies S.J., Phillips L.,Griffiths A.M., Russel L., Naish P.F., Russel G.I. What really happens to people on long-term peritoneal dialysis. Kidney Int.1998; 54: 2202-2217.Davies S.J., Phillips L.,Griffiths A.M., Russel L., Naish P.F., Russel G.I. What really happens to people on long-term peritoneal dialysis. Kidney Int.1998; 54: 2202-2217.Davies S. How to maintain fluid balance in long-term peritoneal dialysis. Perit.Dial.Int.1999; 19, suppl. 2: S 332-S 336.Davies S. How to maintain fluid balance in long-term peritoneal dialysis. Perit.Dial.Int.1999; 19, suppl. 2: S 332-S 336.Fenton S.S.A., Shaubel D.E., Desmeules M., Morrison H.I., Mao Y., Copleston P. et al. Hemodialysis versus peritoneal dialysis: A comparison of adjusted mortality rates. Am.J.Kidney Dis.1997; 30:332-342.Fenton S.S.A., Shaubel D.E., Desmeules M., Morrison H.I., Mao Y., Copleston P. et al. Hemodialysis versus peritoneal dialysis: A comparison of adjusted mortality rates. Am.J.Kidney Dis.1997; 30:332-342.Flessner M.F. Changes in the peritoneal interstitium and their effect on peritoneal transport. Perit.Dial.Int.1999; 19, suppl. 2: S77-S82.Flessner M.F. Changes in the peritoneal interstitium and their effect on peritoneal transport. Perit.Dial.Int.1999; 19, suppl. 2: S77-S82.Gokal R. Peritoneal dialysis: Global Update. Perit.Dial.Int.1999; 19, Suppl.2: S11-S15.Gokal R. Peritoneal dialysis: Global Update. Perit.Dial.Int.1999; 19, Suppl.2: S11-S15.Gokal R., Jacubowsky C., King C., Hunt L., Boyle et al. Outcome in patients on CAPD and hemodialysis: A four year analysis of a prospective multicentre study. Lancet.1987; ii: 1105-1109.Gokal R., Jacubowsky C., King C., Hunt L., Boyle et al. Outcome in patients on CAPD and hemodialysis: A four year analysis of a prospective multicentre study. Lancet.1987; ii: 1105-1109.Gokal R. Extending time on therapy with Extraneal. 3 European Peritoneal Dialysis Meeting. 1998.Gokal R. Extending time on therapy with Extraneal. 3 European Peritoneal Dialysis Meeting. 1998.Heimburger O., Wang T., Lindholm B. Alteratoin in water and solute transport with time on peritoneal dialysis. Perit.Dial.Int.1999; 19, suppl. 2: S 83-S 90.Heimburger O., Wang T., Lindholm B. Alteratoin in water and solute transport with time on peritoneal dialysis. Perit.Dial.Int.1999; 19, suppl. 2: S 83-S 90.Heimburger O., Waniewski J., Werynski A., Tranaeus A., Lindholm B. Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity. Kidney Int.1990; 38: 495-506.Heimburger O., Waniewski J., Werynski A., Tranaeus A., Lindholm B. Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity. Kidney Int.1990; 38: 495-506.Kawagushi Yo. Peritoneal dialysis as long-term treatment: comparison of technique survival between Asian and Western populations. Perit. Dial. Int. 1999; 19, suppl. 2: S327-S328.Kawagushi Yo. Peritoneal dialysis as long-term treatment: comparison of technique survival between Asian and Western populations. Perit. Dial. Int. 1999; 19, suppl. 2: S327-S328.Krediet R.T., Zweers M.M., Ho-dac-Pannekeet M.M., van der Wal A.C. et al. The effect of various dialysis solutions on peritoneal membrane viability. Perit.Dial.Int.1999; 19, suppl. 2: S257-S266.Krediet R.T., Zweers M.M., Ho-dac-Pannekeet M.M., van der Wal A.C. et al. The effect of various dialysis solutions on peritoneal membrane viability. Perit.Dial.Int.1999; 19, suppl. 2: S257-S266.Krediet R.T., Boeschoten E.W., Zuyderhoudt F.M.A., Arisz L. Peritoneal transport characteristics of water, lowmolecular weight solutes and proteins during long-term continuous ambulatory peritoneal dialysis. Perit. Dial. Bull. 1986; 6:61-65.Krediet R.T., Boeschoten E.W., Zuyderhoudt F.M.A., Arisz L. Peritoneal transport characteristics of water, lowmolecular weight solutes and proteins during long-term continuous ambulatory peritoneal dialysis. Perit. Dial. Bull. 1986; 6:61-65.Liberek T., Topley N., Mistry C.D. et al. Cell function and viability in glucose polymer peritoneal dialysis fluids. Perit. Dial. Int.1993; 13:104-111.Liberek T., Topley N., Mistry C.D. et al. Cell function and viability in glucose polymer peritoneal dialysis fluids. Perit. Dial. Int.1993; 13:104-111.Maiorka R., Vonesh E.F., Cavalli P.L., De Vecchi A. et al. A multicentre selection adjusted comparison of patient and technique survival on CAPD and hemodialysis. Perit.Dial.Int.1991;11: 1148-1157.Maiorka R., Vonesh E.F., Cavalli P.L., De Vecchi A. et al. A multicentre selection adjusted comparison of patient and technique survival on CAPD and hemodialysis. Perit.Dial.Int.1991;11: 1148-1157.Monquil M.C., Imholz A.L., Strujik D.G., Krediet R.T. Does impai-red transcellular water transport contribute to net ultrafiltration failure during CAPD? Perit.Dial.Int.1995; 15: 42-48.Monquil M.C., Imholz A.L., Strujik D.G., Krediet R.T. Does impai-red transcellular water transport contribute to net ultrafiltration failure during CAPD? Perit.Dial.Int.1995; 15: 42-48.Mulder J., Krediet R.T. Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis. Nephrol. Dial. Transplant. 1997; 12:A181.Mulder J., Krediet R.T. Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis. Nephrol. Dial. Transplant. 1997; 12:A181.Ota K., Mineshima M., Watanabe N., Naganuma S. Functional deterioration of the peritoneum: does it occur in the absence of peritonitis? Nephrol. Dial. Transplant. 1987; 2:30-33.Ota K., Mineshima M., Watanabe N., Naganuma S. Functional deterioration of the peritoneum: does it occur in the absence of peritonitis? Nephrol. Dial. Transplant. 1987; 2:30-33.Park M.S. a. Lee H.B. AGE accumulation in peitoneal membrane and cavity during peritoneal dialysis and its effect on peritoneal structure and function. Perit.Dial.Int.1999; 19, suppl. 2: S53-S57.Park M.S. a. Lee H.B. AGE accumulation in peitoneal membrane and cavity during peritoneal dialysis and its effect on peritoneal structure and function. Perit.Dial.Int.1999; 19, suppl. 2: S53-S57.Pollock C.A., Ibels L.S., Halett M.D., Cocksedge B. et al. Loss ultrafiltration in continuous ambulatory peritoneal dialysis (CAPD). Perit. Dial. Int. 1989; 9:107-110.Pollock C.A., Ibels L.S., Halett M.D., Cocksedge B. et al. Loss ultrafiltration in continuous ambulatory peritoneal dialysis (CAPD). Perit. Dial. Int. 1989; 9:107-110.Rippe B., Carlson O. Role of transcellular water channels in peritoneal dialysis. Perit.Dial.Int.1999; 19, suppl. 2: S 95-S 101.Rippe B., Carlson O. Role of transcellular water channels in peritoneal dialysis. Perit.Dial.Int.1999; 19, suppl. 2: S 95-S 101.Ronco C., Feriani M., Virga G., Amici G., LaGreca G. Peritoneal dialysis: adequacy beyong Kt/V. Per. Dial. Int. 1999; V.19, Suppl.2, S32.Ronco C., Feriani M., Virga G., Amici G., LaGreca G. Peritoneal dialysis: adequacy beyong Kt/V. Per. Dial. Int. 1999; V.19, Suppl.2, S32.Selgas R., Fernandes-Reyes M.J., Bosque E., Bajo M.-A. et al. Functional longevity of the human peritoneum: How long is continuous peritoneal dialysis possible? Results of a prospective medium long-term study. Am J Kidney Dis. 1994; 23; 64-73.Selgas R., Fernandes-Reyes M.J., Bosque E., Bajo M.-A. et al. Functional longevity of the human peritoneum: How long is continuous peritoneal dialysis possible? Results of a prospective medium long-term study. Am J Kidney Dis. 1994; 23; 64-73.Slater N.D., Cope G.H., Raftery A.T. Peritoneal ultrafiltration after chronic exposure to dialysis fluid. Perit.Dial.Int.1992; 12: 48-50.Slater N.D., Cope G.H., Raftery A.T. Peritoneal ultrafiltration after chronic exposure to dialysis fluid. Perit.Dial.Int.1992; 12: 48-50.Topley N., Mackenzie R.K., Peterson M.M. et al. In vitro testing a potentially biocompatible continuous ambulatory peritoneal dialysis fluid. Nephrol. Dial. Transplant. 1991; 6: 574-581.Topley N., Mackenzie R.K., Peterson M.M. et al. In vitro testing a potentially biocompatible continuous ambulatory peritoneal dialysis fluid. Nephrol. Dial. Transplant. 1991; 6: 574-581.Twardowski Z.J., Nolph K.D., Khanna R., Prowant B.F. et al. Peritoneal equilibration test. Perit. Dial. Bull. 1987; 7: 138-147.Twardowski Z.J., Nolph K.D., Khanna R., Prowant B.F. et al. Peritoneal equilibration test. Perit. Dial. Bull. 1987; 7: 138-147.Wang T., Heimburger O., Waniewski J., Bergstrom G., Lindholm B. Icreased peritoneal permeability is associated with decreased fluid and small solute removal and higher mortality in CAPD patients. Nephrol. Dial. Transplant. 1998; 13: 1242-1279.Wang T., Heimburger O., Waniewski J., Bergstrom G., Lindholm B. Icreased peritoneal permeability is associated with decreased fluid and small solute removal and higher mortality in CAPD patients. Nephrol. Dial. Transplant. 1998; 13: 1242-1279.Weiss M., Saxena A.K., Monnier V.M. Pharmacological modulation of AGE’s: a unique role for redox-active metal ions. Perit. Dial. Int. 1999; 19, Suppl. 2: S62-S67.Weiss M., Saxena A.K., Monnier V.M. Pharmacological modulation of AGE’s: a unique role for redox-active metal ions. Perit. Dial. Int. 1999; 19, Suppl. 2: S62-S67.

The authors declare that there are no conflicts of interest present.